Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |